CCH - MSRA and VRE

	Share This Page
	Send an E-Card
	Contact Us
	Improve This Page
	Printer Friendly
	Printer Friendly

Infection Prevention and Control

- MRSA and VRE

Our Rates

Methicillin-resistant Staphylococcus (MRSA)

Vancomycin-resistant Enterococci (VRE)

Our Rates

MRSA Rate:

The method of calculation of the MRSA bacteraemia infection rate for the reporting period (on a quarterly basis) is:

Number of nosocomial patients with laboratory identification of MRSA bacteraemia X 1000
_______________________________________________________________________
Total # of patient days (quarterly)

Where the numerator is the total number of newly identified cases for MRSA bacteraemia associated with the reporting facility, for the reporting period. The denominator is the total number of in-patient days for the reporting period. There are no exclusion criteria.

VRE Rate

The method of calculation of the VRE bacteraemia infection rate for the reporting period (on a quarterly basis) is:

Number of nosocomial patients with laboratory identification of VRE bacteraemia X 1000
______________________________________________________________________
Total # of patient days (quarterly)

Where the numerator is the total number of newly identified cases for VRE bacteraemia associated with the reporting facility, for the reporting period. The denominator is the total number of in-patient days for the reporting period. There are no exclusion criteria.

The McConnell site has 137 beds.

McConnell Site	10/2016 - 12/2016	1/2017 - 3/2017	4/2017 - 6/2017	7/2017 - 9/2017
Number of new MRSA cases	<5
MRSA Rate	0.08	0.66	0.00	0.07
Number of new VRE cases	0	0	0	0
VRE Rate	0.00	0.00	0.00	0.00

Sitemap | Privacy Policy | Foundation Site